Business Wire

REPLY

Share
REPLY: Politecnico di Torino And Reply Reaffirm Their Commitment to Training Tomorrow’s Digital Experts With the Second Edition of the Second-level Master's in ARTIFICIAL INTELLIGENCE & CLOUD

Following the success of the first edition and the satisfaction shown by all the students who participated in the training path, and now in working in corporate projects, Reply and the Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino announce that enrolment is now open for the second edition of the second-level Master's degree course in "Artificial Intelligence & Cloud Hands-on innovation" .

Starting in January 2022 , the Master’s offers 40 highly qualified students a professional specialisation path in the IT sector through its most innovative technologies: artificial intelligence, machine learning and cloud .

The lessons will be held in person at the Politecnico di Torino and will combine Politecnico di Torino professors and Reply specialists in a mix of theoretical lessons and practical live cases . During the programme, students will work in groups on live projects at Reply , where they will put into practice the knowledge acquired in the classroom.

The Master's is open to students who have previously obtained a Master's degree in either Computer Science, Computer Engineering, Automation Engineering, Telecommunications Engineering, Electronic Engineering and Cybersecurity (the degree must be completed by December 31, 2021). The entire course is in English and it is open to international entrants.

Applications should be submitted online by October 22, 2021 following the instructions available at master.reply.com . This will be followed by an evaluation process in which a commission made up of members of the Politecnico di Torino and Reply professionals will assess the candidates' curricula, educational background and professional experience. The commission will also meet each candidate for an individual interview.

The “Earn While You Learn” formula has also been confirmed for this second edition. Reply commits to hire the selected candidates right from the start of the programme and to bear all the costs of participation in the Master’s for those who accept the job offer.

“Through this specialisation path, in collaboration with the Politecnico di Torino, we aim to create an elite group of students who are highly qualified in the most innovative IT issues and to progressively include these students in our projects” explains Filippo Rizzante, Reply CTO. “Artificial intelligence, machine learning and cloud are fundamental for Reply and for our customers, which is why we want to train students in these technologies right from the start.”

"The Master’s in collaboration with Reply – explains the Specializing Master's Programmes and Lifelong Learning School’s Director, Prof. Paolo Neirotti – is one of the initiatives of excellence that the Master’s School designs and delivers. The programme has a custom-made approach for sector leaders and confirms that the digital transformation requires the various profiles coming out of Master's degrees in Engineering to have hyper-technical specialisation. As a technical university, we are well prepared to provide this specialisation as we design Master's programmes that integrate, recombine and extend the different scientific areas within our second-level training offer. On top of this we also rely on our experience in company applied research and technology."

Politecnico di Torino is recognized as one of the most respected universities in Europe and Reply is a company that has made innovation and technological specialization its flagship. Both entities have joined forces to create a training path for excellence; one aimed at preparing the professionals the industry needs to face the challenges of the future.

More information available at master.reply.com and https://didattica.polito.it/master/ai_cloud/2022/at_a_glance .

°°°

REPLY
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com

Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino
The Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino was founded in December 2011 with the aim of organising and managing first-level and second-level Master’s programmes, as well as Lifelong Learning courses, including executive courses. The School stands out for the variety and multidisciplinary nature of its Master’s programmes and training courses, which are an expression of the many scientific and cultural areas present within a research university such as the Politecnico di Torino. The training offer proposed by the School covers several disciplinary areas in order to provide support to companies and public and private institutions, so that they develop their transition ability towards new technological, economic and social paradigms (e.g. electrification, sustainability, digital transformation). Consistent with the polytechnic tradition, the scientific areas underpinning the School's continuing education offer are related to Industry 4.0, new forms of mobility, development and technology transfer in aerospace, digital transformation of businesses, public administration and society, environmental and energy sustainability, digitalisation in construction, new approaches and new frontiers in design, and the design of territories in the perspective of resilience.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye